R. Kouzy

发表

Sponsor‐involved statistical analyses in Phase III cancer clinical trials

C. Fuller, K. Do, C. Taniguchi, 2020, International journal of cancer.

Professional Medical Writer Assistance in Oncology Clinical Trials

C. Fuller, C. Taniguchi, C. Rödel, 2020, The oncologist.

The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials.

C. Taniguchi, A. Koong, C. Rödel, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Performance Status Restriction in Phase III Cancer Clinical Trials.

Charles R. Thomas, R. Jagsi, Benjamin D. Smith, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials

Charles R. Thomas, R. Jagsi, C. Fuller, 2022, Cancers.

Exclusion of Older Adults in COVID-19 Clinical Trials

C. Taniguchi, Timothy A Lin, V. Subbiah, 2020, Mayo Clinic Proceedings.

Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

A. Jazaeri, L. Ramondetta, A. Futreal, 2022, Cancer Immunology Research.

Microbiome factors in HPV-driven carcinogenesis and cancers

C. Taniguchi, S. Noticewala, A. Klopp, 2020, PLoS pathogens.

Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies.

C. Taniguchi, S. Noticewala, E. Ludmir, 2020, Current problems in cancer.

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

E. Holliday, C. Taniguchi, A. Koong, 2020, Advances in radiation oncology.

A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

A. Jazaeri, N. Ajami, J. Wargo, 2021, PloS one.

Inclusion of premenopausal women in breast cancer clinical trials

W. Woodward, Benjamin D. Smith, S. Giordano, 2022, Breast.

Candidate HPV-Specific T-Cells Expand in the Tumor Microenvironment During Chemoradiotherapy

A. Jazaeri, E. Holliday, J. Wargo, 2021 .

Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity

C. Taniguchi, M. Bhutani, P. Angsuwatcharakon, 2021, Cancers.

Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy

C. Taniguchi, E. Ludmir, D. Lin, 2020, Cancers.

E. Holliday, N. Ajami, J. Wargo, 2023, Frontiers in Immunology.

Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter

Jabra Zarka, Ramez Kouzy, Joseph Abi Jaoude, 2020, Cureus.

Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation.

E. Holliday, C. Taniguchi, B. Minsky, 2020, JCO oncology practice.

Impact factor and citation metrics in phase III cancer trials

C. Taniguchi, B. Minsky, E. Ludmir, 2021, Oncotarget.

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

E. Holliday, C. Taniguchi, A. Koong, 2021, Advances in Radiation Oncology.

Microbiome Dynamics During Chemoradiotherapy for Anal Cancer.

E. Holliday, N. Ajami, J. Petrosino, 2022, International journal of radiation oncology, biology, physics.

Association of Gut Microbiome Characteristics With the Late Gastrointestinal Toxicities After Pelvic Receiving Radiation Treatment for Cervical, Vaginal, and Anal Cancers.

N. Ajami, D. Lin, C. Taniguchi, 2021, International journal of radiation oncology, biology, physics.

Adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

A. Jazaeri, N. Ajami, J. Wargo, 2020, bioRxiv.

Cancer Research after COVID-19: Where Do We Go from Here?

C. Taniguchi, E. Ludmir, L. Colbert, 2020, Cancer Cell.

Microbiome Dynamics During Chemoradiotherapy for Anal Cancer

E. Holliday, N. Ajami, J. Petrosino, 2021, medRxiv.

Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.

C. Taniguchi, B. Minsky, P. Das, 2023, Cancer.

S. Peterson, J. Gunther, S. Parsons, 2023, Supportive Care in Cancer.

A Case of Typical Hemolytic Uremic Syndrome in an Adult

S. Temraz, R. Kouzy, Fares Sukhon, 2018, Cureus.

Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades

C. Taniguchi, A. Koong, B. Minsky, 2020, BMJ Supportive & Palliative Care.

Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.

E. Fokas, T. Meirson, P. Msaouel, 2023, European journal of cancer.

Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions.

E. Ludmir, R. Kouzy, G. Manzar, 2023, Seminars in radiation oncology.

Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials

E. Koay, P. Msaouel, E. Ludmir, 2024, BMJ Oncology.

Food and Drug Administration approvals in phase 3 Cancer clinical trials

C. Fuller, C. Taniguchi, B. Minsky, 2021, BMC Cancer.

Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic

A. Koong, P. Lin, A. Klopp, 2024, BMJ supportive & palliative care.